{"id":27911,"date":"2024-10-28T11:58:48","date_gmt":"2024-10-28T10:58:48","guid":{"rendered":"https:\/\/ggba.swiss\/?p=27911"},"modified":"2024-10-28T11:58:52","modified_gmt":"2024-10-28T10:58:52","slug":"three-innovative-geneva-based-start-ups-receive-fif-funding","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/","title":{"rendered":"Three innovative Geneva-based start-ups receive FIF funding"},"content":{"rendered":"\n<p>The FONGIT Innovation Fund (<a href=\"https:\/\/www.fongit.ch\/financing\">FIF<\/a>) has granted CHF 250,000 to three pioneering Geneva-based start-ups in the fields of cleantech, life sciences and virtual reality: Dyneo Technologies, Adoram Therapeutics and ex vivo. These companies will receive a combination of seed loans and grants to further their technological advances and innovations in sustainable energy, drug discovery and medical education.<\/p>\n\n\n\n<p><strong>Reducing energy losses in central heating systems<\/strong><\/p>\n\n\n\n<p>ICT and cleantech start-up <a href=\"https:\/\/www.dyneo.ch\/\">Dyneo Technologies<\/a> has been awarded a FIF seed loan of CHF 100,000. Its innovative software aims to reduce thermal losses in district heating systems, contributing to energy efficiency and decarbonization. By optimizing network performance and reducing operating costs, Dyneo&#8217;s solution addresses key challenges in sustainable energy management. The project is led by co-founders Ma\u00ebl Perret and Max Carrel.<\/p>\n\n\n\n<p><strong>Advancing drug discovery in immuno-oncology<\/strong><\/p>\n\n\n\n<p><a href=\"https:\/\/adoram.ch\/\">Adoram Therapeutics<\/a>, a life sciences spin-off from the University of Geneva, has received a FIF seed loan of CHF 100,000 to advance its innovative drug discovery platform. Using an allosteric approach, the company&#8217;s platform enhances drug efficacy while minimizing toxicity, initially targeting immuno-oncology and autoimmune diseases. Under the leadership of Hesham Hamed, Adoram is attracting interest from pharmaceutical companies exploring potential partnerships and clinical trial advancements.<\/p>\n\n\n\n<p><strong>Transforming medical education through virtual reality<\/strong><\/p>\n\n\n\n<p>With a CHF 50,000 FIF grant, ex vivo, led by Oliver Alan Kannape of Geneva University Hospitals (HUG), is developing a virtual reality (VR) tool for medical education. This immersive VR platform allows students to simulate final year clinical examinations (OSCEs), enhancing training without the logistical need for actors and resources. The innovation, supported by HUG and the Swiss Foundation For Innovation And Training In Surgery (<a href=\"https:\/\/www.sfits.ch\/sfits-startup\/\">SFITS<\/a>), promises to transform assessment in medical education.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Three Geneva-based start-ups &#8211; Dyneo Technologies, Adoram Therapeutics and ex vivo &#8211; have received CHF 250,000 from the FONGIT Innovation Fund to advance solutions in cleantech, life sciences and virtual reality.<\/p>\n","protected":false},"author":6,"featured_media":27912,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[839],"tags":[949,936,894,890,974,911,899,901,931],"class_list":["post-27911","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tech-en","tag-education-en","tag-energy","tag-financing","tag-healthcare","tag-ict","tag-pharma","tag-sustainability","tag-technology-park","tag-virtual-reality"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Three innovative Geneva-based start-ups receive FIF funding<\/title>\n<meta name=\"description\" content=\"Three Geneva-based start-ups have received CHF 250,000 from the FIF to advance solutions in cleantech, life sciences and virtual reality.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Three innovative Geneva-based start-ups receive FIF funding\" \/>\n<meta property=\"og:description\" content=\"Three Geneva-based start-ups have received CHF 250,000 from the FIF to advance solutions in cleantech, life sciences and virtual reality.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-28T10:58:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-28T10:58:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/FIF-Funding-Adoram-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Three innovative Geneva-based start-ups receive FIF funding\",\"datePublished\":\"2024-10-28T10:58:48+00:00\",\"dateModified\":\"2024-10-28T10:58:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/\"},\"wordCount\":283,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/FIF-Funding-Adoram-1180x811-1.jpg\",\"keywords\":[\"Education\",\"Energy\",\"Financing\",\"Healthcare\",\"ICT\",\"Pharma\",\"Sustainability\",\"Technology Park\",\"Virtual Reality\"],\"articleSection\":[\"Tech\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/\",\"url\":\"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/\",\"name\":\"Three innovative Geneva-based start-ups receive FIF funding\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/FIF-Funding-Adoram-1180x811-1.jpg\",\"datePublished\":\"2024-10-28T10:58:48+00:00\",\"dateModified\":\"2024-10-28T10:58:52+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Three Geneva-based start-ups have received CHF 250,000 from the FIF to advance solutions in cleantech, life sciences and virtual reality.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/FIF-Funding-Adoram-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/FIF-Funding-Adoram-1180x811-1.jpg\",\"width\":1180,\"height\":811,\"caption\":\"The team at Adoram Therapeutics has received a CHF 100,000 Seed Loan from the FONGIT Innovation Fund to advance drug discovery with its innovative platform, targeting critical needs in immuno-oncology and autoimmune diseases. | \u00a9 FONGIT\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Three innovative Geneva-based start-ups receive FIF funding\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Three innovative Geneva-based start-ups receive FIF funding","description":"Three Geneva-based start-ups have received CHF 250,000 from the FIF to advance solutions in cleantech, life sciences and virtual reality.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/","og_locale":"en_US","og_type":"article","og_title":"Three innovative Geneva-based start-ups receive FIF funding","og_description":"Three Geneva-based start-ups have received CHF 250,000 from the FIF to advance solutions in cleantech, life sciences and virtual reality.","og_url":"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-10-28T10:58:48+00:00","article_modified_time":"2024-10-28T10:58:52+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/FIF-Funding-Adoram-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Three innovative Geneva-based start-ups receive FIF funding","datePublished":"2024-10-28T10:58:48+00:00","dateModified":"2024-10-28T10:58:52+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/"},"wordCount":283,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/FIF-Funding-Adoram-1180x811-1.jpg","keywords":["Education","Energy","Financing","Healthcare","ICT","Pharma","Sustainability","Technology Park","Virtual Reality"],"articleSection":["Tech"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/","url":"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/","name":"Three innovative Geneva-based start-ups receive FIF funding","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/FIF-Funding-Adoram-1180x811-1.jpg","datePublished":"2024-10-28T10:58:48+00:00","dateModified":"2024-10-28T10:58:52+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Three Geneva-based start-ups have received CHF 250,000 from the FIF to advance solutions in cleantech, life sciences and virtual reality.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/FIF-Funding-Adoram-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/FIF-Funding-Adoram-1180x811-1.jpg","width":1180,"height":811,"caption":"The team at Adoram Therapeutics has received a CHF 100,000 Seed Loan from the FONGIT Innovation Fund to advance drug discovery with its innovative platform, targeting critical needs in immuno-oncology and autoimmune diseases. | \u00a9 FONGIT"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/three-innovative-geneva-based-start-ups-receive-fif-funding\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Three innovative Geneva-based start-ups receive FIF funding"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/27911","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=27911"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/27911\/revisions"}],"predecessor-version":[{"id":27915,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/27911\/revisions\/27915"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/27912"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=27911"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=27911"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=27911"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}